June 6, 2024 — Scientists in the United Kingdom have pinpointed genetic factors that appear to drive inflammatory bowel disease, and laboratory experiments using existing drugs […]

NASHVILLE, TENNESSEE — Stress in patients with multiple sclerosis (MS) can have serious effects on quality of life, but there is some evidence that it could […]

WASHINGTON, DC — Microbiota-focused dietary therapy could improve disease outcomes and management of metabolic dysfunction-associated steatotic liver disease (MASLD), according to a study presented at the […]

NASHVILLE, Tennessee — In a multicenter collaboration, patients with multiple sclerosis (MS) who developed hypogammaglobulinemia (HGG) after treatment with ocrelizumab or ofatumumab were found to have […]

LONG BEACH, California — Because women are underrepresented in clinical trials evaluating endovascular therapy with stent implantation and bypass surgery for symptomatic femoropopliteal peripheral artery disease […]

MILAN — Fecal microbiota transplantation (FMT), also known as intestinal microbiota transplantation, significantly reduced recurrence of hepatic encephalopathy compared with placebo in patients with cirrhosis on […]

Despite the influx of adalimumab biosimilars entering the market in 2023, Humira remains on top. As of January 2024, both high and low concentrations of Humira, […]

The addition of abemaciclib to fulvestrant significantly improved progression-free survival for patients with hormone receptor positive, HER2 negative advanced breast cancer who had been previously treated […]

Liver transplantation plus chemotherapy significantly improves overall survival in carefully selected patients with unresectable colorectal liver metastases compared with chemotherapy alone, according to the results of […]